Pierluigi Paracchi, CEO and Co-founder of Genenta Science, is scheduled to present at the U.S. Senate meeting titled 'Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective' on October 25, 2024.
The event, organized by the U.S. National Security Commission on Emerging Biotechnology (NSCEB) and the Italian Embassy in the U.S., will feature Mr. Paracchi as a speaker and moderator of the Italian Working Group on the Internationalization of the Biotech Sector (NWTIB). He will present the recently released Interim Report from the NWTIB.
This participation underscores Genenta's role in shaping international biotechnology strategies and provides a platform for the company to highlight its innovative work to a high-profile audience. Such engagement can enhance the company's reputation and attract strategic interest within the global life sciences community.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.